FAMDF (Futura Medical) Insider Ownership : 0.00 % (As of Apr. 19, 2025)

View and export this data going back to 2007. Start your Free Trial

What is Futura Medical Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Futura Medical's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Futura Medical's Institutional Ownership is 3.40%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Futura Medical's Float Percentage Of Total Shares Outstanding is 0.00%.

Futura Medical Insider Ownership Historical Data

The historical data trend for Futura Medical's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Insider Ownership Chart

Futura Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Insider Ownership

Get a 7-Day Free Trial

Futura Medical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Insider Ownership	Get a 7-Day Free Trial															-	-	-	-	-

Futura Medical Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Futura Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (OTCPK:FAMDF) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

FUM:UK GYX:Germany

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.